Tactile Systems Technology, Inc. (TCMD)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$21.87-0.64%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · TCMD
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||
| Revenues | 350.3 | 329.5 | 293.0 | 274.4 | 246.8 | 208.1 | 187.1 | 189.5 | 143.8 | 109.3 | 84.5 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 109.3 | 84.5 |
| Cost of Revenues | 81.3 | 79.4 | 76.3 | 79.3 | 70.8 | 59.8 | 54.3 | 55.3 | 41.5 | 29.0 | 22.9 |
| Gross Profit | 269.0 | 250.1 | 216.7 | 195.1 | 176.0 | 148.2 | 132.8 | 134.2 | 102.3 | 80.3 | 61.6 |
| Operating Expenses & Income | |||||||||||
| R&D Expenses | 10.0 | 8.5 | 8.8 | 7.8 | 7.1 | 5.7 | 5.3 | 5.2 | 5.3 | 5.1 | 4.5 |
| Operating Income | 35.0 | 29.3 | 22.2 | 18.0 | (12.8) | (1.8) | (3.6) | 10.5 | 3.0 | 3.9 | 4.3 |
| Earnings from Continuing Operations | |||||||||||
| Interest Expense | — | 1.0 | 2.1 | — | — | — | — | — | — | — | — |
| Interest & Investment Income | 2.6 | 3.1 | 3.4 | 1.9 | 0.1 | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | — | — | — | (2.3) | (2.7) | (0.5) | 1.4 | 0.6 | 0.5 | 0.3 | 0.0 |
| Asset Writedown | — | — | — | — | — | — | 4.0 | 2.5 | 2.5 | — | — |
| EBT, Incl. Unusual Items | 37.4 | 31.3 | 23.5 | 15.8 | (15.5) | (2.3) | (2.3) | 11.1 | 3.5 | 4.2 | 4.3 |
| Income Tax Expense | 12.5 | 12.3 | 6.5 | (12.7) | 2.4 | 9.5 | (1.6) | 0.2 | (3.1) | (1.7) | 1.4 |
| Net Income | |||||||||||
| Net Income | 24.9 | 19.1 | 17.0 | 28.5 | (17.9) | (11.8) | (0.6) | 11.0 | 6.6 | 5.9 | 2.9 |
| Per Share | |||||||||||
| Basic EPS | 1.10 | 0.83 | 0.71 | 1.24 | (0.89) | (0.60) | (0.03) | 0.58 | 0.36 | 0.34 | 0.18 |
| Diluted EPS | 1.08 | 0.82 | 0.70 | 1.23 | (0.89) | (0.60) | (0.03) | 0.56 | 0.34 | 0.31 | 0.15 |
| Revenue per Share | 15.19 | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 22.7 | 22.9 | 23.9 | 22.9 | 20.1 | 19.7 | 19.3 | 18.9 | 18.3 | 17.4 | 8.9 |
| Diluted Weighted Avg Shares | 23.1 | 23.3 | 24.1 | 23.2 | 20.1 | 19.7 | 19.3 | 19.6 | 19.3 | 18.9 | 10.8 |
| Supplemental | |||||||||||
| EBITDA | — | 35.9 | 29.0 | 24.6 | (6.5) | 1.9 | (0.8) | 14.0 | 6.7 | 5.7 | 5.1 |
| EBIT | 35.0 | 29.3 | 22.2 | 18.0 | (12.8) | (1.8) | (3.6) | 10.5 | 3.0 | 3.9 | 4.3 |
| Effective Tax Rate | 33.4% | — | — | -80.8% | -15.5% | -415.1% | 72.6% | 1.4% | -90.5% | -39.7% | 33.2% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.